Table 1.
Baseline characteristics of the patients
| MLF | ||||
|---|---|---|---|---|
| All (n = 72) | + (n = 27) | − (n = 45) | P | |
| Female, n (%) | 38 (52.8) | 17 (63.0) | 21 (46.7) | .180 |
| Age, years | 59.7 ± 18.8 | 61.9 ± 15.3 | 58.4 ± 20.6 | .460 |
| Body weight, kg | 58.5 ± 12.9 | 56.3 ± 10.7 | 59.7 ± 14.0 | .284 |
| BMI, kg/m2 | 22.5 ± 3.2 | 22.3 ± 2.8 | 22.6 ± 3.5 | .638 |
| Sum of facial measurements, cm | 69.0 ± 4.0 | 68.3 ± 3.6 | 69.5 ± 4.3 | .204 |
| Initial oral prednisolone dosage, mg/day | 31.8 ± 13.7 | 40.6 ± 8.6 | 26.6 ± 13.6 | <.001 |
| Pulsed steroids, n (%) | 12 (16.7) | 1 (3.7) | 11 (24.4) | .022 |
| Other immunosuppressive therapies, n (%) | 48 (66.7) | 23 (85.2) | 25 (55.6) | .010 |
| HbA1c, % | 5.9 [5.5–6.4] | 5.9 [5.6–6.1] | 5.9 [5.5–6.8] | .767 |
| Underlying disease | ||||
| Microscopic polyangiitis, n (%) | 11 (15.3) | 7 (25.9) | 4 (8.9) | .052 |
| Polymyalgia rheumatica, n (%) | 7 (9.7) | 2 (7.4) | 5 (11.1) | .608 |
| IgA nephropathy, n (%) | 5 (6.9) | 0 (0) | 5 (11.1) | .073 |
| Others | 49 (68.1) | 18 (66.7) | 31 (68.9) | .845 |
| Other diseases | ||||
| Diabetes, n (%) | 14 (19.4) | 2 (7.4) | 12 (26.7) | .046 |
| Hypertension, n (%) | 27 (37.5) | 8 (29.6) | 19 (42.2) | .285 |
| Dyslipidemia, n (%) | 33 (45.8) | 12 (44.4) | 21 (46.7) | .855 |
Abbreviations: BMI, body mass index; HbA1c, hemoglobin A1c; MLF, moon-like facies.
Values are shown as mean ± SD and median [25th percentile value–75th percentile value].